Signal from the log
Familiar Therapeutics
5 M$ · Seed · United States · Biotech
Familiar Therapeutics prend sous licence des médicaments déjà étudiés chez l'humain et mène les essais et la fabrication nécessaires pour les faire autoriser par la FDA chez le chien et le chat. Créée il y a cinq mois, elle compte treize programmes, en cancérologie, neurologie et cardiologie.
Verified
Announced on , logged by the watch of 22 October 2026.
- Operation
- Funding round
- Announced amount
- 5 M$
- Stage
- Seed
- Country
- United States
- Sector
- Biotech
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Pioneer Fund , Icehouse Ventures , BreakTHRU , with business angels
Provenance
Source businesswire
Logged on 22 October 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.